LAS VEGAS, March 16, 2026 /PRNewswire/ — XCMG Group, one of China’s foremost construction machinery enterprises, concluded a landmark appearance at CONEXPO-CON/AGG 2026 in Las Vegas, marking the company’s 11th consecutive participation in the world’s largest construction trade exhibition. Competing alongside nearly 3,000 exhibitors from across the globe, XCMG used this year’s show to demonstrate a pivotal strategic evolution: the transition from simply exporting products to establishing genuine, lasting roots in North America’s premium market.

North America has long held a reputation as a high-bar market where performance, reliability, and innovation are non-negotiable. XCMG rose to that challenge by presenting 35 machine models specially engineered for North American operating conditions, covering core construction scenarios including earth-moving, lifting, aerial work platforms, and mining applications.

The highlight of XCMG’s exhibit was the global launch of the PRO Series. The next-generation product line built for the North American professional. PRO Series machines feature deep integration of intelligent interaction and precision control technologies, offering operators fully customizable parameters, intuitive visual interfaces, and advanced self-diagnostic capabilities. The result is a machine that transforms complex operations into clear, controllable tasks — raising both operator confidence and overall job-site productivity.

“This reflects a broader transformation in Chinese construction machinery — moving from scale advantage to technology edge. We are no longer simply offering cost-effective tools; we are exporting advanced engineering solutions, earning the respect and trust of premium global markets through innovation.”

— Zhai Kun, General Manager, XCMG Global Business Headquarters & XCMG Import & Export Co., Ltd.

XCMG’s North American strategy reflects this philosophy in tangible terms. The company has built a sophisticated local support infrastructure to back up its technology ambitions. Millions of dollars in spare parts are now stocked at XCMG’s North American warehouses, enabling rapid response and minimal machine downtime. Over 95% of XCMG’s North American workforce is locally hired. This is the testament to the company’s commitment to embedding itself into the fabric of the regional market rather than operating as a foreign vendor.

“Our North American parts inventory has been fully optimized to ensure the highest possible uptime for every machine we put in the field,” said Liu Quan, XCMG’s North America Director. “Regardless of equipment type, our local team is ready to provide around-the-clock support.”

This operational depth is central to XCMG’s pitch to North American customers: the company provides comprehensive, intelligent, and scenario-specific construction solutions backed by a local team that understands the demands of the market.

XCMG’s presence at CONEXPO-CON/AGG 2026 is part of a broader global growth trajectory. The company’s products now reach more than 190 countries and regions worldwide. Along the markets of the Belt and Road Initiative, XCMG commands a coverage rate exceeding 95%. International revenue now accounts for nearly half of XCMG’s total business, reinforcing the company’s standing as one of China’s most prominent ambassadors for advanced manufacturing on the world stage.

With its combination of purpose-built technology, deep local investment, and expanding global reach, XCMG leaves CONEXPO 2026 not merely as a participant, but as a formidable long-term contender in the world’s most demanding construction machinery market.

HONG KONG, March 16, 2026 /PRNewswire/ — KLN Logistics Group Limited (‘KLN’; Stock Code 0636.HK) is pleased to announce that its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), is now the full-line distributor for APT Medical Inc.’s (‘APT Medical’; Stock Code 688617.SH) coronary intervention products in Hong Kong. KLN Medical will promote and distribute APT Medical’s full coronary intervention portfolio while providing clinical application training, after-sales support and logistics services. This collaboration aims to strengthen support for medical professionals and patients and advance the adoption of percutaneous coronary intervention technologies in Hong Kong.

APT Medical offers a comprehensive portfolio of interventional cardiology products, encompassing key devices such as angiography triads, guiding catheters, percutaneous transluminal coronary angioplasty (PTCA) guidewires, microcatheters, extension catheters, and PTCA balloons. These products provide excellent patency and operational stability, meeting the demands of both routine and complex percutaneous coronary interventions. Leveraging KLN’s established medical logistics infrastructure, these products will be delivered efficiently to major public and private hospitals across Hong Kong. With extensive experience in medical device logistics, cold chain handling, warehousing and inventory management, KLN Medical provides responsive and flexible supply chain support to healthcare institutions, helping enhance clinical operational efficiency.  

Samuel Lau, Managing Director – Integrated Logistics of KLN, said, “We are honoured to partner with APT Medical to offer more options to Hong Kong healthcare institutions and patients through cost-effective, reliable and advanced treatment solutions. With our flexible logistics solutions and commitment to service excellence, we will support the long-term development of the interventional cardiology device market in Hong Kong.”

Fangyuan Liu, Deputy General Manager of APT Medical, said, “As a leading manufacturer and supplier in the interventional cardiology device sector, we are delighted to establish the partnership with KLN Medical. Leveraging KLN’s extensive local experience and robust logistics capabilities in the Hong Kong market, we are confident in enabling more healthcare institutions and patients to benefit from our advanced, reliable and cost-effective coronary intervention solutions.”

About KLN Logistics Group Limited (Stock Code 0636.HK)
KLN is an Asia-based, global 3PL with a highly diversified business portfolio and extensive coverage in Asia. It offers a broad range of supply chain solutions from integrated logistics, international freight forwarding (air, ocean, road, rail and multimodal) and e-commerce to industrial project logistics and infrastructure investment.

With a global presence across 59 countries and territories, KLN has established a solid foothold in half of the world’s emerging markets. Its diverse infrastructure, extensive coverage in international gateways and local expertise span across the Chinese Mainland, India, Southeast Asia, the CIS, Middle East, LATAM and other locations.

KLN generated a revenue* of close to HK$60 billion in 2024. It is listed on the Hong Kong Stock Exchange and is a constituent of the Hang Seng Corporate Sustainability Benchmark Index.

* For continuing operations only

About KLN Medical Limited 
KLN Medical is dedicated to advancing healthcare in Hong Kong and Southeast Asia by delivering innovative medical technologies that improve patient outcomes. In collaboration with world-renowned partners, KLN Medical ensures that healthcare professionals have access to the latest advancements, driving excellence across the continuum of care. As a member of the KLN Group, KLN Medical focuses on the reliable distribution of high-quality medical devices and solutions. Its multidisciplinary team brings deep expertise across key areas including cardiovascular care, rehabilitation, hospital and clinic support, engineering, marketing, business development, regulatory affairs and quality assurance, customer service, and operations. Website: www.medical.kln.com

About APT Medical Inc. 
Founded in 2002, APT Medical is a leading manufacturer and supplier of EP and Vascular Intervention medical devices, committed to advancing interventional medicine utilizing technologies and innovations. Our ever-expanding product portfolio spans Electrophysiology, Cardiology, Peripheral, and Neurointervention, providing reliable tools that support clinicians worldwide. With innovation at the forefront of our mission, APT Medical remains steadfast in its commitment to being a leader in the interventional field while protecting the health of humanity. As of the second half of 2024, APT products are used in over 1,360 hospitals for electrophysiology and more than 4,000 hospitals for vascular intervention, and are exported to 90+ countries and regions worldwide.

HONG KONG, March 16, 2026 /PRNewswire/ — KLN Logistics Group Limited (‘KLN’; Stock Code 0636.HK) is pleased to announce that its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), is now the full-line distributor for APT Medical Inc.’s (‘APT Medical’; Stock Code 688617.SH) coronary intervention products in Hong Kong. KLN Medical will promote and distribute APT Medical’s full coronary intervention portfolio while providing clinical application training, after-sales support and logistics services. This collaboration aims to strengthen support for medical professionals and patients and advance the adoption of percutaneous coronary intervention technologies in Hong Kong.

APT Medical offers a comprehensive portfolio of interventional cardiology products, encompassing key devices such as angiography triads, guiding catheters, percutaneous transluminal coronary angioplasty (PTCA) guidewires, microcatheters, extension catheters, and PTCA balloons. These products provide excellent patency and operational stability, meeting the demands of both routine and complex percutaneous coronary interventions. Leveraging KLN’s established medical logistics infrastructure, these products will be delivered efficiently to major public and private hospitals across Hong Kong. With extensive experience in medical device logistics, cold chain handling, warehousing and inventory management, KLN Medical provides responsive and flexible supply chain support to healthcare institutions, helping enhance clinical operational efficiency.  

Samuel Lau, Managing Director – Integrated Logistics of KLN, said, “We are honoured to partner with APT Medical to offer more options to Hong Kong healthcare institutions and patients through cost-effective, reliable and advanced treatment solutions. With our flexible logistics solutions and commitment to service excellence, we will support the long-term development of the interventional cardiology device market in Hong Kong.”

Fangyuan Liu, Deputy General Manager of APT Medical, said, “As a leading manufacturer and supplier in the interventional cardiology device sector, we are delighted to establish the partnership with KLN Medical. Leveraging KLN’s extensive local experience and robust logistics capabilities in the Hong Kong market, we are confident in enabling more healthcare institutions and patients to benefit from our advanced, reliable and cost-effective coronary intervention solutions.”

About KLN Logistics Group Limited (Stock Code 0636.HK)
KLN is an Asia-based, global 3PL with a highly diversified business portfolio and extensive coverage in Asia. It offers a broad range of supply chain solutions from integrated logistics, international freight forwarding (air, ocean, road, rail and multimodal) and e-commerce to industrial project logistics and infrastructure investment.

With a global presence across 59 countries and territories, KLN has established a solid foothold in half of the world’s emerging markets. Its diverse infrastructure, extensive coverage in international gateways and local expertise span across the Chinese Mainland, India, Southeast Asia, the CIS, Middle East, LATAM and other locations.

KLN generated a revenue* of close to HK$60 billion in 2024. It is listed on the Hong Kong Stock Exchange and is a constituent of the Hang Seng Corporate Sustainability Benchmark Index.

* For continuing operations only

About KLN Medical Limited 
KLN Medical is dedicated to advancing healthcare in Hong Kong and Southeast Asia by delivering innovative medical technologies that improve patient outcomes. In collaboration with world-renowned partners, KLN Medical ensures that healthcare professionals have access to the latest advancements, driving excellence across the continuum of care. As a member of the KLN Group, KLN Medical focuses on the reliable distribution of high-quality medical devices and solutions. Its multidisciplinary team brings deep expertise across key areas including cardiovascular care, rehabilitation, hospital and clinic support, engineering, marketing, business development, regulatory affairs and quality assurance, customer service, and operations. Website: www.medical.kln.com

About APT Medical Inc. 
Founded in 2002, APT Medical is a leading manufacturer and supplier of EP and Vascular Intervention medical devices, committed to advancing interventional medicine utilizing technologies and innovations. Our ever-expanding product portfolio spans Electrophysiology, Cardiology, Peripheral, and Neurointervention, providing reliable tools that support clinicians worldwide. With innovation at the forefront of our mission, APT Medical remains steadfast in its commitment to being a leader in the interventional field while protecting the health of humanity. As of the second half of 2024, APT products are used in over 1,360 hospitals for electrophysiology and more than 4,000 hospitals for vascular intervention, and are exported to 90+ countries and regions worldwide.

A Shooting-Focused Sport Designed to Tackle Japan’s “Lack of Finishing Power” and Overcome the “Fear of Failure” Soccer Culture

TOKYO, March 16, 2026 /PRNewswire/ — LEIFRAS Co., Ltd. (Nasdaq: LFS) (the “Company” or “Leifras”), a sports and social business company dedicated to youth sports and community engagement, today announced the official launch of “SIX SHOOT”, a new soccer competition focused on shooting and goal scoring. SIX SHOOT was conceived by Leifras employee and former J.League player Itta Terada, aiming to foster a mindset among young people to embrace challenges and shoot without fear of failure through sports. The Company has also launched official social media accounts for the competition and plans to share updates on how various prestigious teams across different age groups take on the SIX SHOOT challenge. The Company also plans to hold tournaments by age groups in the future.

Development Background: Addressing the Need for a Goal-Scoring Mindset in Japanese Soccer
One of the long-standing issues facing Japanese soccer is the lack of strikers. Partly due to Japan’s strong culture that values harmony, Japanese players tend to choose a “100% success rate back pass” over a “50% success rate shot” in critical moments. However, to compete at the highest levels and realize the goal of winning the World Cup, players must develop the confidence and technical ability to seize even the smallest opportunities in front of goal. Taking a shot is the very essence of “challenge” in life. SIX SHOOT was born from the belief that more players, and more people beyond the field, should develop a “shoot without fear” mindset: the resolve to shape their own future on their own terms, despite the risk of receiving criticism if they miss.

What is “SIX SHOOT”? A New Shooting-Focused Competition Format
SIX SHOOT is a “shooting-focused competitive event” where players attempt six different types of shots and compete to score the most goals. It is designed to hone the players’ shooting skills under match-like pressure and engage the social media audience with its clear outcome—whether a goal is scored or not. Promotion and rule explanation videos can be viewed via the competition’s official accounts.

• Six Designated Situations
  Penalty kick, direct shot, one-touch shot, mid-range shot, etc.
• Win or Lose Determination
  The player who scores the most goals (or the goalkeeper who has made the most saves) at the end of the sixth round is the winner.
• Match Format
  Competitions can be held in individual or team formats, with flexible structures depending on the number of participants and categories.

Going Forward: Age-Group Tournaments to Cultivate Japan’s Next Generation of Strikers
SIX SHOOT is more than just entertainment. As a serious project aimed at discovering the world’s best striker, age-group tournaments are being planned for players aged U-9 (3^rd grade elementary school) and above to determine the top striker in each age group. By focusing on shooting, Leifras seeks to improve the shooting skills and mindset of young players.

Launch of Official Social Media Accounts Under the Theme “The World’s Best Striker, From Japan”
The official social media accounts for this project have been launched. The Company plans to share the journey of founder Itta Terada’s challenges, the practice of SIX SHOOT by prestigious teams from each age group, spectacular plays from SIX SHOOT competitions, and showdown events featuring star guests.

Official Social Media Accounts: SIX SHOOT | The World’s Best Striker, From Japan.

• Instagram: https://www.instagram.com/six_shoot_lfs/
• TikTok: https://www.tiktok.com/@six_shoot_lfs

About LEIFRAS Co., Ltd.
Headquartered in Tokyo, Leifras is a sports and social business company dedicated to youth sports and community engagement. The Company primarily provides services related to the organization and operations of sports schools and sports events for children. As of December 31, 2024, Leifras was recognized as one of Japan’s largest operators of children’s sports schools in terms of both membership and facilities by Tokyo Shoko Research. The Company’s approach to sports education emphasizes the development of non-cognitive skills, following the teaching principle “acknowledge, praise, encourage, and motivate.” The holistic approach that integrates physical and mental development sets Leifras apart in the industry. Building upon deep experience and know-how in sports education, Leifras also operates a robust social business sector, dispatching sports coaches to meet various community needs with the aim to promote physical health, social inclusion, and community well-being across different demographics.

For more information, please visit the Company’s website: https://ir.leifras.co.jp/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the registration statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

For more information, please contact:

LEIFRAS Co., Ltd.
Investor Relations Department
Email: IR@leifras.co.jp

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com